Literature DB >> 23337001

Management of juvenile myasthenia gravis.

Cristian M Ionita1, Gyula Acsadi.   

Abstract

Juvenile myasthenia gravis is an uncommon autoimmune disorder. Its management is not standardized. Juvenile myasthenia gravis is pathophysiologically similar to myasthenia gravis in adults. However, a number of significant particularities related to race, age at onset, severity, and antibody status complicate the management. We summarize the unique clinical features of juvenile myasthenia gravis and review the therapeutic options.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23337001     DOI： 10.1016/j.pediatrneurol.2012.07.008

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN： 0887-8994            Impact factor:   3.372


  9 in total

1.  Toddler with Ptosis: Now You See It, Now You Don't.

Authors:  Qingwen Kawaji; Carla R Watson; Lalitha Sivaswamy
Journal:  Paediatr Child Health       Date:  2018-06-18       Impact factor: 2.253

2.  Long-term outcome of 424 childhood-onset myasthenia gravis patients.

Authors:  Mengcui Gui; Xuan Luo; Jing Lin; Yue Li; Min Zhang; Xiaofan Zhang; Mingshan Yang; Wei Wang; Bitao Bu
Journal:  J Neurol       Date:  2015-01-15       Impact factor: 4.849

3.  Application of Pyridostigmine in Pediatric Gastrointestinal Motility Disorders: A Case Series.

Authors:  Mhd Louai Manini; Michael Camilleri; Rayna Grothe; Carlo Di Lorenzo
Journal:  Paediatr Drugs       Date:  2018-04       Impact factor: 3.022

4.  Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.

Authors:  Pedro M Rodríguez Cruz; Michal Al-Hajjar; Saif Huda; Leslie Jacobson; Mark Woodhall; Sandeep Jayawant; Camilla Buckley; David Hilton-Jones; David Beeson; Angela Vincent; Maria Isabel Leite; Jacqueline Palace
Journal:  JAMA Neurol       Date:  2015-06       Impact factor: 18.302

5.  Treatment of MuSK-Associated Myasthenia Gravis.

Authors:  Khalid El-Salem; Ahmed Yassin; Kefah Al-Hayk; Salma Yahya; Duha Al-Shorafat; Said S Dahbour
Journal:  Curr Treat Options Neurol       Date:  2014-04       Impact factor: 3.972

6.  Analysis of serum miRNA profiles of myasthenia gravis patients.

Authors:  Gisela Nogales-Gadea; Alba Ramos-Fransi; Xavier Suárez-Calvet; Miquel Navas; Ricard Rojas-García; Jose Luis Mosquera; Jordi Díaz-Manera; Luis Querol; Eduard Gallardo; Isabel Illa
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

7.  Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China.

Authors:  Xin Huang; Yingkai Li; Huiyu Feng; Pei Chen; Weibin Liu
Journal:  Front Neurol       Date:  2018-02-27       Impact factor: 4.003

Review 8.  Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies.

Authors:  Hans Frykman; Pankaj Kumar; Joel Oger
Journal:  Front Neurol       Date:  2020-12-09       Impact factor: 4.003

9.  Myasthenia Gravis Masquerading as Status Asthmaticus.

Authors:  Neha Pirwani; Shayna Wrublik; Shashikanth Ambati
Journal:  Case Rep Pediatr       Date:  2021-12-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.